Skip to main content

Table 1 Subject demographic and clinical characteristics by 30-day mortality

From: The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia

Variable

30-day mortality

p

 

Alive (n = 138)

Dead (n = 34)

 

Age (years)

63.9 ± 16

61.8 ± 14

0.2

Men

123 (90)

27 (79)

0.1

Nursing home resident

14 (10)

4 (11)

0.7

Emergency department admission

126 (91)

30 (88)

0.6

Admitted to intensive care =24 hours

82 (59)

24 (71)

0.6

Mechanical ventilation

52 (37)

3 (8)

<0.001

Pre-existing comorbid conditions

   

   Congestive heart failure

36 (26)

5 (15)

0.2

   Chronic pulmonary disease

45 (33)

8 (24)

0.3

   History of stroke

30 (22)

4 (12)

0.2

   Chronic liver disease

13 (9)

6 (18)

0.17

   History of malignancy

13 (9)

11 (32)

0.001

   Renal insufficiency

4 (3)

0

0.3

History, physical, laboratory, and radiographic data

   

   Altered mental status

33 (24)

9 (26)

0.8

   Respiratory rate >30 per minute

29 (21)

8 (24)

0.7

   Systolic blood pressure <90 mmHg

6 (4)

1 (3)

0.7

   Heart rate >125 per minute

29 (21)

14 (41)

0.015

   Temperature <95°C or >104°C

7 (5)

2 (6)

0.8

   Arterial pH <7.35

25 (18)

11 (32)

0.07

   Arterial oxygenation <90%

52 (38)

16 (47)

0.3

   Hematocrit <30%

21 (15)

2 (6)

0.15

   Blood urea nitrogen >30 mg/dl

58 (42)

15 (44)

0.8

   Serum glucose >250 mg/dl

21 (15)

3 (8)

0.3

   Serum sodium <130 meq/l

30 (22)

8 (24)

0.8

   Pleural effusion

48 (35)

17 (50)

0.1

   Multilobar infiltrates

64 (47)

18 (52)

0.5

Pneumonia severity index

   

   Class I to III

34 (25)

6 (18)

 

   Class IV

40 (29)

8 (24)

 

   Class V

64 (46)

20 (58)

0.4

Processes of care

   

   Initial antibiotics within 4 hours

46 (30)

10 (29)

0.7

   Blood cultures prior to antibiotics

110 (79)

29 (85)

0.45

   Oxygenation assessed =24 hours

120 (87)

30 (88)

0.8

  1. Data are presented as number (%) or mean ± SD.